Cancer Letters
Volume 208, Issue 2 , Pages 163-170 , 28 May 2004

Induction of apoptosis in human lung cancer cells by curcumin

Received 14 July 2003 ,Revised 24 September 2003 ,Accepted 12 January 2004.

References 

  1. Huang MT, Lou YR, Xie JG, Ma W, Lu YP, Yen P, et al.  Effect of dietary curcumin and dibenzoylmethane on formation of 7,12- dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis. 1998;19:1697–1700
  2. Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res. 1997;57:1301–1305
  3. Verma SP, Salamone E, Goldin B. Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides. Biochem. Biophys. Res. Commun. 1997;233:692–696
  4. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855–4878
  5. Bhaumik S, Jyothi MD, Khar A. Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. Fed. Eur. Biochem. Sci. Lett. 2000;483:78–82
  6. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell. 1997;91:443–446
  7. Nagata S. Apoptosis by death factor. Cell. 1997;88:355–365
  8. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322–1326
  9. Farrow SN, Brown R. New members of the Bcl-2 family and their protein partners. Curr. Opin. Genet. Dev. 1996;6:45–49
  10. Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett. 2001;172:111–118
  11. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 1993;53:3976–3985
  12. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, et al.  Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol. Biol. Cell. 2002;13:978–988
  13. Gajate C, Santos-Beneit AM, Macho A, Lazaro M, Hernandez-De Rojas A, Modolell M, et al.  Involvement of mitochondria and caspase-3 in ET-18-OCH(3)-induced apoptosis of human leukemic cells. Int. J. Cancer. 2000;86:208–218
  14. Oetari S, Sudibyo M, Commandeur JN, Samhoedi R, Vermeulen NP. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem. Pharmacol. 1996;51:39–45
  15. Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr. Pharm. Des. 2002;8:1695–1706
  16. Supino R, Perego P, Gatti L, Caserini C, Leonetti C, Colantuono M, et al.  A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line. Eur. J. Cancer. 2001;37:2247–2256
  17. Strasser A, Harris AW, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53- independent mechanisms inhibitable by Bcl-2. Cell. 1994;79:329–339
  18. Ramachandran C, You W. Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res. Treat. 1999;54:269–278
  19. Hipp ML, Bauer G. Intercellular induction of apoptosis in transformed cells does not depend on p53. Oncogene. 1997;15:791–797
  20. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, et al.  p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene. 1995;11:493–504
  21. Adachi H, Preston G, Harvat B, Dawson MI, Jetten AM. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma. Am. J. Respir. Cell. Mol. Biol. 1998;18(3):323–333
  22. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799–1805
  23. Scott RJ, Krummenacher F, Mary JL, Weber W, Spycher M, Muller H. Hereditary p53 mutation in a patient with multiple tumors: significance for genetic counseling. Schweiz. Med. Wochenschr. 1993;123:1287–1292
  24. Prendergast GC. Mechanisms of apoptosis by c-Myc. Oncogene. 1999;18:2967–2987
  25. Ragimov N, Krauskopf A, Navot N, Rotter V, Oren M, Aloni Y. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene. 1993;8:1183–1193
  26. Hermeking H, Eick D. Mediation of c-Myc-induced apoptosis by p53. Science. 1994;265:2091–2093
  27. Sakamuro D, Eviner V, Elliott KJ, Showe L, White E, Prendergast GC. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene. 1995;11:2411–2418
  28. Wesierska-Gadek J, Bugajska-Schretter A, Cerni C. ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modified. J. Cell Biochem. 1996;62:90–101
  29. Wesierska-Gadek J, Schmid G. Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint. J. Cell Biochem. 2000;80:85–103
  30. Cohen GM. Caspases: the executioners of apoptosis. Biochem. J. 326. 1997;326(Pt1):1–16
  31. Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 1998;273:9357–9360
  32. Pandey S, Smith B, Walker PR, Sikorska M. Caspase-dependent and independent cell death in rat hepatoma 5123tc cells. Apoptosis. 2000;5:265–275
  33. Merino R, Grillot DA, Simonian PL, Muthukkumar S, Fanslow WC, Bondada S, et al. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J. Immunol. 1995;155:3830–3838
  34. Duyao MP, Kessler DJ, Spicer DB, Sonenshein GE. Binding of NF-KB-like factors to regulatory sequences of the c-myc gene. Curr. Top. Microbiol. Immunol. 1990;166:211–220
  35. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Brenner C, Larochette N, et al.  Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. 1999;189:381–394
  36. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 1999;274:5053–5060
  37. Zhang H, Heim J, Meyhack B. Novel BNIP1 variants and their interaction with BCL2 family members. Fed. Eur. Biochem. Sci. Lett. 1999;448:23–27
  38. Reed JC. Mechanisms of apoptosis avoidance in cancer. Curr. Opin. Oncol. 1999;11:68–75
  39. Cheng EH, Levine B, Boise LH, Thompson CB, Hardwick JM. Bax-independent inhibition of apoptosis by Bcl-XL. Nature. 1996;379:554–556
  40. Pratesi G, Polizzi D, Perego P, Dal Bo L, Zunino F. Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs. Biochem. Pharmacol. 2000;60:77–82

PII: S0304-3835(04)00053-9

doi: 10.1016/j.canlet.2004.01.008

Cancer Letters
Volume 208, Issue 2 , Pages 163-170 , 28 May 2004

Article Tools

* Image Usage & Resolution